
Ivalink OD 10mg Tablet PR
Marketer
Lincoln Pharmaceuticals Ltd
Salt Composition
Ivabradine (10mg)
Overview Ivalink OD 10mg Tablet PR
Ivalink OD 10mg Tablet PR is prescribed for angina pectoris (chest pain linked to the heart) and long-standing congestive heart failure. It improves cardiac function by reducing heart rate, thereby alleviating chest discomfort and lowering the likelihood of hospital admission for heart failure patients. Dosage is determined by the specific condition being treated. Because treatment for angina or heart failure is generally ongoing, discontinuation requires prior consultation with your physician. Consistent daily administration with food is recommended. Overdosage can lead to bradycardia (excessively slow heart rate), fatigue, and shortness of breath; seek immediate medical attention if this occurs. Common side effects include transient visual disturbances, bradycardia, hypertension, atrial fibrillation, vertigo, blurred vision, and electrocardiographic abnormalities. Serious adverse events, such as syncope (fainting) and significant cardiac rhythm changes, necessitate prompt medical evaluation. Refrain from driving until the medication's effects are understood. Ivalink OD 10mg Tablet PR is contraindicated in patients with severe hepatic impairment, resting bradycardia, cardiac arrhythmias, significantly low blood pressure, or recently exacerbated heart failure. It may interact negatively with certain antihypertensives, antifungals, and antiretrovirals. Avoid use during pregnancy, attempts at conception, or breastfeeding.
Uses of Ivalink OD 10mg Tablet PR
Managing angina pectoris and heart failure.
Major Benefits of Ivalink OD 10mg Tablet PR:
Follow your physician's instructions or consult the product labeling for usage guidance. Administer Ivalink OD 10mg Tablet PR with a meal.
Common Side effects of Ivalink OD 10mg Tablet PR:
- Slow heart rate
- Luminous phenomena (Enhanced brightness)
- High blood pressure
- Atrial fibrillation
- Dizziness
- Blurred vision
- ECG changes
How to use Ivalink OD 10mg Tablet PR:
Follow your physician's instructions or consult the product label for dosage guidance. Consume Ivalink OD 10mg Tablet PR with food.
How Ivalink OD 10mg Tablet PR works:
Ivalink OD 10mg tablets (PR) are prescribed to decrease heart rate. This medication achieves its effect by slowing the heart's rhythm, thereby diminishing the heart's oxygen demand and improving its overall efficiency.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Ivalink OD 10mg Tablet PR is not known to be safe. Seek medical advice before combining them.
PregnancyUNSAFE
Using Ivalink OD 10mg tablets during pregnancy poses a substantial risk. Pregnant women should consult their physician; research in animals and human studies indicates considerable harm to the fetus.
Breast feedingUNSAFE
Breastfeeding mothers should avoid Ivalink OD 10mg tablets. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by Ivalink OD 10mg Tablet PR, a medication that can induce temporary visual disturbances, primarily phosphenes. The potential for these light flashes should be considered, particularly during nighttime driving.
KidneyCAUTION
Ivalink OD 10mg Tablet PR requires careful administration in individuals with severely impaired kidney function. Dosage modification for Ivalink OD 10mg Tablet PR might be necessary. Physician consultation is advised. Data regarding Ivalink OD 10mg Tablet PR use in patients with severe renal insufficiency is limited.
LiverCAUTION
Patients with liver impairment should exercise caution when using Ivalink OD 10mg Tablet PR, potentially requiring a modified dosage. Medical advice is recommended. Ivalink OD 10mg Tablet PR is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Ivalink OD 10mg Tablet PR :
Omit any missed Ivalink OD 10mg Tablet PR dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ivalink OD 10mg Tablet PR
| Label | Value |
|---|---|
| Chemical Category | Benzazepine-based compound |
| Developing Habits | No. |
| Treatment Category | Heart |
| Actions | Sinoatrial node I<sub>f</sub> sodium channel blockers |
